I
Idorsia
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients
At a glance
- Status
- Listed
- Listing
- IPO 2017
Open roles
Idorsia in the Allschwil ecosystem
The Idorsia office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Alumni founders
Former Idorsia employees who went on to found companies, sorted by Dealroom signal score.
ATAlentis TherapeuticsEst. 2019
Francois LamourSwitzerland
REResilienceEst. 2020
Sandy MahatmeUnited States
Lucas VançonFrance
Tobias WerkSwitzerlandPatents
167 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Idorsia on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Idorsia starts pivotal Phase 3 trial for Fabry disease drug lucerastat and signs Asia-Pacific deal with Nxera
Idorsia partners with Jamjoom Pharma to bring QUVIVIQ to Saudi Arabia and the Levant
